Urgent reversal of warfarin with prothrombin complex concentrate

This publication has 15 references indexed in Scilit:

• Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
  New England Journal of Medicine, 2005
• Guidelines for the use of fresh‐frozen plasma, cryoprecipitate and cryosupernatant
  British Journal of Haematology, 2004
• Reversal of Warfarin-Induced Excessive Anticoagulation with Recombinant Human Factor VIIa Concentrate
  Annals of Internal Medicine, 2002
• Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Risk of Bleeding
  Thrombosis and Haemostasis, 2001
• Use of Factor IX Complex in Warfarin-related Intracranial Hemorrhage
  Neurosurgery, 1999
• Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal
  Clinical and Laboratory Haematology, 1998
• Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/
  The American Journal of Medicine, 1998
• Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)
  The Lancet, 1996
• The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin
  Annals of Internal Medicine, 1996
• Emergency reversal of anticoagulation after intracerebral hemorrhage.
  Stroke, 1992